Founded in 2018, Seattle-based Alpenglow Biosciences is a privately held, early-stage life sciences company focused on accelerating drug development and improving clinical diagnostics with AI-enabled, 3D imaging technology. Our platform solution provides new spatial biology insights with greater accuracy by digitizing entire tissues while keeping samples intact for additional analysis. Alpenglow partners with pharmaceutical companies to develop better therapeutics and greater understanding of biodistribution, mechanism of action, and rank ordering of potential candidates using our patented technology. Five of the top 10 pharma companies work with Alpenglow to accelerate development timelines, gain new insights, and improve therapeutic success.

3D Technology

Health Care

Life Sciences

Alpenglow Biosciences

Nicholas Reder

Steve Pemberton

Alex Springer

Cody Cooper

Caleb Stoltzfus

The Leadership Team at Alpenglow Biosciences is responsible for setting the strategic direction of the company and driving its mission to enhance drug development and clinical diagnostics. This team collaborates to leverage AI-enabled 3D imaging technology, form partnerships with pharmaceutical leaders, and ensure the alignment of scientific innovation with commercial objectives. Through their expertise, they guide the company in accelerating therapeutic advancements and optimizing product development processes.

Leadership Team

Engineering Team

Research Team

Leadership Team

About

Team members

Other teams at Alpenglow Biosciences

Engineering Team

Research Team